ArticleCancer control : journal of the Moffitt Cancer Center

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.

Yanqiao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.